DK524585D0 - Cholecalciferolderivater - Google Patents

Cholecalciferolderivater

Info

Publication number
DK524585D0
DK524585D0 DK524585A DK524585A DK524585D0 DK 524585 D0 DK524585 D0 DK 524585D0 DK 524585 A DK524585 A DK 524585A DK 524585 A DK524585 A DK 524585A DK 524585 D0 DK524585 D0 DK 524585D0
Authority
DK
Denmark
Prior art keywords
cholecalciferal
derivatives
cholecalciferal derivatives
Prior art date
Application number
DK524585A
Other languages
English (en)
Other versions
DK524585A (da
DK159652B (da
DK159652C (da
Inventor
Enrico Baggiolini
Giacomo Pizzolato
Milan Uskokovic
Gary Truitt
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK524585D0 publication Critical patent/DK524585D0/da
Publication of DK524585A publication Critical patent/DK524585A/da
Publication of DK159652B publication Critical patent/DK159652B/da
Application granted granted Critical
Publication of DK159652C publication Critical patent/DK159652C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C7/00Purification; Separation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/44Halogenated unsaturated alcohols containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C07C45/305Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Analytical Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Water Supply & Treatment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK524585A 1984-11-16 1985-11-13 Cholecalciferolderivater, disse derivater til brug som terapeutisk aktive substanser, fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat baseret paa disse cholecalciferolderivater DK159652C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/672,059 US4613594A (en) 1984-11-16 1984-11-16 Fluorinated vitamin D3 compounds
US67205984 1984-11-16

Publications (4)

Publication Number Publication Date
DK524585D0 true DK524585D0 (da) 1985-11-13
DK524585A DK524585A (da) 1986-05-17
DK159652B DK159652B (da) 1990-11-12
DK159652C DK159652C (da) 1991-04-08

Family

ID=24696990

Family Applications (1)

Application Number Title Priority Date Filing Date
DK524585A DK159652C (da) 1984-11-16 1985-11-13 Cholecalciferolderivater, disse derivater til brug som terapeutisk aktive substanser, fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat baseret paa disse cholecalciferolderivater

Country Status (21)

Country Link
US (1) US4613594A (da)
EP (1) EP0182298B1 (da)
JP (1) JPS61122237A (da)
KR (1) KR930007993B1 (da)
AR (1) AR242767A1 (da)
AT (1) ATE48412T1 (da)
AU (1) AU588012B2 (da)
CA (1) CA1286693C (da)
DE (1) DE3574587D1 (da)
DK (1) DK159652C (da)
ES (1) ES8801198A1 (da)
FI (1) FI84599C (da)
HU (1) HU194162B (da)
IE (1) IE58851B1 (da)
IL (1) IL77052A (da)
MC (1) MC1709A1 (da)
NO (1) NO162906C (da)
NZ (1) NZ214175A (da)
PH (1) PH21540A (da)
PT (1) PT81502B (da)
ZA (1) ZA858151B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63196556A (ja) * 1987-02-10 1988-08-15 Taisho Pharmaceut Co Ltd 含フツ素ビタミンd誘導体
US5316770A (en) * 1989-02-16 1994-05-31 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
WO1990009179A1 (en) * 1989-02-16 1990-08-23 University Of Georgia Research Foundation, Inc. Treatment of tibial dyschondroplasia
US5366736A (en) * 1989-02-16 1994-11-22 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
JP2525478B2 (ja) * 1989-03-01 1996-08-21 帝人株式会社 安定性の改良された活性型ビタミンd▲下3▼類固型製剤
AU650751B2 (en) * 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
US5278155A (en) * 1991-06-05 1994-01-11 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and cell differentiation-inducing agent containing the same
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
DE69213844T2 (de) * 1991-07-05 1997-04-10 Duphar Int Res Vitamin-D Derivat, Verfahren zu dessen Herstellung sowie Zwischenprodukte dafür
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5753638A (en) * 1992-10-07 1998-05-19 Hoffmann-La Roche Inc. Method of treating hyperproliferative skin disease with Vitamin D3 fluorinated analogs
US5547947A (en) * 1993-03-11 1996-08-20 Hoffmann-La Roche Inc. Methods of treatment
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
AU2005303773A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin D derivatives and anti-proliferative agents for treating bladder cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248791A (en) * 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
JPS57149224A (en) * 1981-03-13 1982-09-14 Chugai Pharmaceut Co Ltd Tumor-suppressing agent
US4358406A (en) * 1981-07-27 1982-11-09 Wisconsin Alumni Research Foundation 26,26,26,27,27,27-Hexafluoro-1α,25-dihydroxycholecalciferol and process for preparing same
US4411833A (en) * 1982-05-26 1983-10-25 Wisconsin Alumni Research Foundation Method for preparing 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxycholesterol
DE3471928D1 (en) * 1983-01-28 1988-07-14 Hoffmann La Roche Process for the preparation of cholecalciferol derivatives
US4508651A (en) * 1983-03-21 1985-04-02 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxyergocalciferol
US4505906A (en) * 1984-01-30 1985-03-19 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 isomers
US4521410A (en) * 1984-05-03 1985-06-04 The General Hospital Corporation Vitamin D glycosyl orthoesters

Also Published As

Publication number Publication date
AR242767A1 (es) 1993-05-31
PH21540A (en) 1987-11-16
DE3574587D1 (de) 1990-01-11
CA1286693C (en) 1991-07-23
IL77052A (en) 1990-02-09
FI854492A0 (fi) 1985-11-14
DK524585A (da) 1986-05-17
ATE48412T1 (de) 1989-12-15
DK159652B (da) 1990-11-12
NO162906B (no) 1989-11-27
PT81502B (pt) 1988-03-03
FI84599B (fi) 1991-09-13
MC1709A1 (fr) 1986-09-22
IE852875L (en) 1986-05-16
IE58851B1 (en) 1993-11-17
NZ214175A (en) 1989-04-26
ES548910A0 (es) 1987-12-16
EP0182298B1 (de) 1989-12-06
JPH051770B2 (da) 1993-01-11
NO854576L (no) 1986-05-20
KR930007993B1 (ko) 1993-08-25
ZA858151B (en) 1986-06-25
IL77052A0 (en) 1986-04-29
KR860004073A (ko) 1986-06-16
DK159652C (da) 1991-04-08
FI854492A (fi) 1986-05-17
AU588012B2 (en) 1989-09-07
PT81502A (en) 1985-12-01
NO162906C (no) 1990-03-07
JPS61122237A (ja) 1986-06-10
HUT39138A (en) 1986-08-28
FI84599C (fi) 1991-12-27
AU5089885A (en) 1986-05-29
HU194162B (en) 1988-01-28
EP0182298A1 (de) 1986-05-28
US4613594A (en) 1986-09-23
ES8801198A1 (es) 1987-12-16

Similar Documents

Publication Publication Date Title
DK268285A (da) Dialkoxypyridinderivater
DK35785A (da) Tetrahydrocarbazolonderivater
DK243985D0 (da) Aminoalkylphenoxyderivater
DE3463503D1 (de) Sulfonamido-benzamide derivatives
ATA232984A (de) Hoergeraet
DE3561395D1 (de) Phenylisothiocyanates
DE3566887D1 (de) Flavanon derivatives
DK524585D0 (da) Cholecalciferolderivater
DK501085D0 (da) Substituerede benzimidazolderivater
DK443685A (da) Pirimidinderivater
DK460785D0 (da) Substituerede furanylderivater
DK536085A (da) Homopropargylaminer
DK320585A (da) Fluorallylaminderivater
ES539508A0 (es) Derivados de androsteno nuevos
DK514585D0 (da) Aminoethylanilinderivater
DK405885A (da) Etherherbicider
DE3565100D1 (de) Cycloalkane-indene-carboximidamide derivatives
DK606385D0 (da) Acylaminoergoliner
DK267190D0 (da) 13-substitueret-5-ketomilbemycinderivater
ATE36715T1 (de) 7-d-mandelamido-3-(1-sulfomethyltetrazol-5us840229
DK54085A (da) Phenylpropargylaminderivater
DK522585D0 (da) Roerformet lyddaemper
DE3564269D1 (de) Eburnane derivatives
DD221422B1 (de) Kennzeichnungsgeraet
ES529437A0 (es) Derivados de 3-pirrolidinopropiofenona

Legal Events

Date Code Title Description
PBP Patent lapsed